Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

T2 Biosystms Inc (TTOO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow T2 Biosystms Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.8400 +0.1000    +3.65%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
2.8500
+0.0100
+0.3521%
0:43:57 - Real-time Data
  • Volume: 136,948
  • Bid/Ask: 2.8100 / 2.9000
  • Day's Range: 2.7001 - 2.9353
Type:  Equity
Market:  United States
T2 Biosystms Inc 2.8400 +0.1000 +3.65%

T2 Biosystms Inc Company Profile

 
Read the T2 Biosystms Inc company profile to learn more about the business and the management team. View T2 Biosystms Inc facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

113

Equity Type

ORD

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Contact Information

Address 101 Hartwell Avenue
Lexington, 02421
United States
Phone 781 761 4646
Fax 781 240 0464

Top Executives

Name Age Since Title
John J. Sperzel 60 2020 President, CEO & Chairman
Peter G. Pappas - 2011 Member of Clinical Advisory Board
Louis B. Rice - 2011 Member of Clinical Advisory Board
Seymour E. Liebman 73 2016 Independent Director
John W. Cumming 78 2014 Lead Independent Director
David B. Elsbree 75 2014 Independent Director
Eric S. Rosenberg - 2011 Member of Clinical Advisory Board
Michael A. Pfaller 72 2014 Member of Clinical Advisory Board
Robin Toft 62 2020 Independent Director
Ninfa M. Saunders 72 2020 Independent Director
Sean X. Zhang - 2022 Member of Scientific Advisory Board
George Pankey - 2022 Member of Scientific Advisory Board
Laura Lee Adams 67 2021 Independent Director
Denise L. Uettwiller-Geiger - 2022 Member of Scientific Advisory Board
M. Hong Nguyen - 2022 Member of Scientific Advisory Board
Thomas J. Walsh - 2022 Member of Scientific Advisory Board
Michael J. Rybak - 2022 Member of Scientific Advisory Board
Randall T. Hayden - 2022 Member of Scientific Advisory Board
James W. Snyder - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TTOO Price Commentary

Write your thoughts about T2 Biosystms Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nadeem Sheikh
Nadeem Sheikh Oct 16, 2023 10:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We need that merger News to come in fast! I'm not sure what the CEO was thinking otherwise!?
Jeff King
Jeff King Sep 28, 2023 16:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This turned into a stinker even with the FDA approval.
Nadeem Sheikh
Nadeem Sheikh Sep 19, 2023 18:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA approved and I've just accumulated more. Lets Gooo..
Fd Avenue
Fd Avenue Sep 19, 2023 16:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lets see if we fill the gap looking unlikely
Aaron Murphy
Aaron Murphy Sep 18, 2023 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fda approval came thru today expect government contracts next
Fd Avenue
Fd Avenue Sep 17, 2023 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Expect this to pump this week .. but be careful
Nadeem Sheikh
Nadeem Sheikh Jul 21, 2023 0:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA appoved. Yeah, I'm holding strong and going to buy more tomorrow!
Aaron Murphy
Aaron Murphy Aug 12, 2022 17:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
reading there pipeline and the huge barda funding and low float unreal potential
Aslice XX
Aslice XX Feb 04, 2021 23:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10x easily in a month!
Nick Navik
Nick Navik Feb 04, 2021 23:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they are not profitable now, but money is going in right direction however what make you so confident about this stock have 10x potential. curious to know. thanks
Aslice XX
Aslice XX Feb 04, 2021 23:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nick Navik  it is my personal view, none of the new start companies are profitable, the projection of its speculative growth rate suggested this case will target at 30% chance to hit $6, 55% chance to hit $7.8 and 35% chance of hitting $11. I bought mine at 0.67c so that is an easy 10x for me.
Pepe Bohington
Pepe Bohington Feb 04, 2021 23:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How did that work out for you?
soksambo mean
soksambo mean Jan 12, 2021 10:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
high rate
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email